329 related articles for article (PubMed ID: 11545598)
1. Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain.
Arndt KM; Müller KM; Plückthun A
J Mol Biol; 2001 Sep; 312(1):221-8. PubMed ID: 11545598
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
Brinkmann U; Di Carlo A; Vasmatzis G; Kurochkina N; Beers R; Lee B; Pastan I
J Mol Biol; 1997 Apr; 268(1):107-17. PubMed ID: 9149145
[TBL] [Abstract][Full Text] [Related]
3. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
4. Bivalent Fv antibody fragments obtained by substituting the constant domains of a fab fragment with heterotetrameric molybdopterin synthase.
Petrov K; Dion M; Hoffmann L; Dintinger T; Defontaine A; Tellier C
J Mol Biol; 2004 Aug; 341(4):1039-48. PubMed ID: 15328616
[TBL] [Abstract][Full Text] [Related]
5. Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.
Plückthun A; Glockshuber R; Skerra A; Stadmüller J
Behring Inst Mitt; 1990 Dec; (87):48-55. PubMed ID: 2096820
[TBL] [Abstract][Full Text] [Related]
6. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
[TBL] [Abstract][Full Text] [Related]
7. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
8. Dimerisation strategies for shark IgNAR single domain antibody fragments.
Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
[TBL] [Abstract][Full Text] [Related]
10. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
Ohage EC; Wirtz P; Barnikow J; Steipe B
J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
[TBL] [Abstract][Full Text] [Related]
11. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
12. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
13. Single chain Fab (scFab) fragment.
Hust M; Jostock T; Menzel C; Voedisch B; Mohr A; Brenneis M; Kirsch MI; Meier D; Dübel S
BMC Biotechnol; 2007 Mar; 7():14. PubMed ID: 17346344
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
15. Generation of a single-chain Fv fragment for the monitoring of deoxycholic acid residues anchored on endogenous proteins.
Kobayashi N; Ohtoyo M; Wada E; Kato Y; Mano N; Goto J
Steroids; 2005 Apr; 70(4):285-94. PubMed ID: 15784283
[TBL] [Abstract][Full Text] [Related]
16. Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression.
Demarest SJ; Chen G; Kimmel BE; Gustafson D; Wu J; Salbato J; Poland J; Elia M; Tan X; Wong K; Short J; Hansen G
Protein Eng Des Sel; 2006 Jul; 19(7):325-36. PubMed ID: 16672248
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
[TBL] [Abstract][Full Text] [Related]
18. Carrier-specificity of a phosphorylcholine-binding antibody requires the presence of the constant domains and is not dependent on the unique VH49 glycine or VH30 threonine residues.
Tam FC; Ma CH; Leung DT; Sutton B; Lim PL
J Immunol Methods; 2007 Apr; 321(1-2):152-63. PubMed ID: 17331532
[TBL] [Abstract][Full Text] [Related]
19. Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation.
Kumada Y; Sakan Y; Kajihara H; Kihara M; Kikuchi Y; Yamaji H; Seong GH; Katoh S
J Biosci Bioeng; 2009 Jan; 107(1):73-7. PubMed ID: 19147114
[TBL] [Abstract][Full Text] [Related]
20. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]